Nrf2-Dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010
Activation of NRF2 is responsible for the overexpression of peroxiredoxin and sulphiredoxin in human lung cancer Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009
Decreased mRNA and protein expression of peroxiredoxin (PRDX6) in the COPD lung Source: Eur Respir J 2004; 24: Suppl. 48, 320s Year: 2004
Expression and cell specific localization of glutathione-S-transferase omega in healthy human lung and COPD Source: Eur Respir J 2006; 28: Suppl. 50, 339s Year: 2006
Adenovirus-mediated AP-2α down-regulates MnSOD expression in lung cancer A549 cells and its molecular mechanism Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011
A neo-epitope of serum lysyl oxidase like 2 (LOXL2) generated during enzyme maturation is elevated in cancer and idiopathic pulmonary disease Source: International Congress 2017 – Techniques in biomarker selection Year: 2017
Choice of endogenous control for gene expression in nonsmall cell lung cancer Source: Eur Respir J 2005; 26: 1002-1008 Year: 2005
Lung cancer in smoking patients inversely alters Fpg and endonuclease III human homologues Source: Eur Respir J 2002; 20: Suppl. 38, 229s Year: 2002
Cell-specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 76s Year: 2001
NADPH oxidase isoform 1 is expressed in lung tissue of ARDS patients and decreases hyperoxia-induced ROS production and cell death in pulmonary type II epithelial cells Source: Annual Congress 2011 - Barrier functions in sepsis and acute lung injury Year: 2011
Localization of cytoglobin, a novel protein, in lung tissues Source: Eur Respir J 2005; 26: Suppl. 49, 551s Year: 2005
Expression of the acute phase protein haptoglobin in human lung cancer and tumor-free lung tissues Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009
Transcriptional regulation of the human osteopontin promoter in non-small cell lung cancer Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011
1-cys peroxiredoxin – a novel antioxidant of human airways Source: Eur Respir J 2001; 18: Suppl. 33, 77s Year: 2001
Regulation of γ-GCS gene expression by TGF-β in type II epithelial cells: role for Fra-1/AP-1/ARE Source: Eur Respir J 2002; 20: Suppl. 38, 96s Year: 2002
Polymorphism in GSTM1, GSTT1, p53 and CCR5 genes and lung cancer progression: relation to p53 and Ki-67 protein expression in tumors of non-small cell lung cancer patients Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006
Fusion transcripts in lung cancer Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017
Expression and function of the 67 kDa high-affinity laminin receptor in nonsmall cell lung carcinoma Source: Eur Respir J 2002; 20: Suppl. 38, 13s Year: 2002
Oral presentation: Truncated isoforms of BRCA1-associated protein BARD1 are expressed in NSCLC and are potential targets for treatment Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009
Carbonic anhydrase 9 expression (CA9e) profile combined with growth patterns (GPs) in non-small cell lung cancer (NSCLC) identifies a group of patients with an extremely poor prognosis Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology Year: 2005